Skip to main content

Table 2 Univariate and multivariate Cox proportional hazards regression analysis for OS

From: Nomogram based on clinical characteristics and serological inflammation markers to predict overall survival of oral tongue squamous cell carcinoma patient after surgery

 

Univariate analysis

Multivariate analysis

HR

95%CI

P

HR

95%CI

P

Gender (female vs. male)

1.099

0.565–2.137

0.782

   

Age (≥ 69 vs. < 69; y)

1.997

0.905–4.408

0.087

3.253

1.353–7.825

0.008

Tumor size (≥ 4.2 vs. < 4.2; cm)

2.945

1.376–6.304

0.005

   

TNM Stage (III–IV vs. I–II)

4.396

2.230–8.664

0.000

4.712

2.272–9.770

0.000

IgG (≥ 12.51 vs. < 12.51; g/L)

0.457

0.225–0.926

0.030

0.385

0.176–0.840

0.017

IgA (≥ 1.97 vs. < 1.97; g/L)

1.474

0.773–2.812

0.239

   

IgM (≥ 1.09 vs. < 1.09; g/L)

0.538

0.273–1.060

0.073

   

C3 (≥ 1.05 vs. < 1.05; g/L)

1.924

0.967–3.830

0.062

   

C4 (≥ 0.22 vs. < 0.22; g/L)

1.582

0.773–3.235

0.209

   

BF (≥ 0.47 vs. < 0.47; g/L)

2.087

0.876–4.968

0.097

   

CRP (≥ 3.78 vs. < 3.78; mg/L)

1.621

0.722–3.638

0.241

   

WBC(≥ 4.95 vs. < 4.95; 109/L)

0.467

0.218–1.003

0.051

   

LMR (≥ 4.15 vs. < 4.15)

0.243

0.110–0.539

0.001

0.408

0.177–0.940

0.035

PLR (≥ 177.86 vs. < 177.86)

2.205

0.913–5.325

0.079

   

NLR (≥ 1.61 vs. < 1.61)

0.682

0.351–1.328

0.261

   
  1. HR, Hazard ratio; 95% CI, 95% confidence interval; TNM, tumor/node/metastasis; IgG, immunoglobulin G; IgA, immunoglobulin A; IgM, immunoglobulin M; C3, Complement 3; C4, Complement 4; BF, B factor; CRP, C-reactive protein; WBC, white blood cell count; LMR, lymphocyte-to-monocyte ratio; PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; OS, overall survival
Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us